·Î°í
HOME CONTACT US
ȸ»ç¼Ò°³ °ÇÃà±â°è¼³ºñ°ø»ç ½ÅÀç»ý¿¡³ÊÁö(Áö¿­ ³Ã/³­¹æ) ä¿ëÁ¤º¸ °í°´¼¾ÅÍ ¹®ÀÇÇϱâ ÀÚ·á½Ç °øÁö»çÇ×
¹®ÀÇÇϱâ
ÀÚ·á½Ç
°øÁö»çÇ×
1:1 »ó´ã¸®½ºÆ®



  HOME > °í°´¼¾ÅÍ > ¹®ÀÇÇϱâ
Á¦¸ñ   WvHqVlSUoTjQjBZlSr
ÀÛ¼ºÀÚ   Lorenzo
ºñ¹Ð¹øÈ£   Á¶È¸¼ö   136
µî·ÏÀÏ   2019/07/30 (00:28)
³» ¿ë How much does the job pay? http://nhentai.in.net/ nhent Analysts at Cowen and Co initiated coverage of thebiotechnology company with an "outperform" rating, saying thecompany"s experimental anticoagulant REG1 could be moreeffective than bivalirudin, a competing drug sold by TheMedicine Co under the brand name Angiomax.
¸®½ºÆ®·Î ´ä±Û´Þ±â ¼öÁ¤Çϱâ Áö¿ì±â
[°ü·ÃµÈ ±Û º¸±â]
41353 WvHqVlSUoTjQjBZlSr Loren.. 2019.07.30 136

ȸ»ç¼Ò°³
°ÇÃ༳ºñ°ø»ç
½ÅÀç»ý¿¡³ÊÁö
¿À½Ã´Â±æ
(ÁÖ)º¸¶÷¿£Áö´Ï¾î¸µ
ȸ»ç¼Ò°³ ¿À½Ã´Â±æ e-mail
1998 BORAM-ENG company. All rights reserved
[143-220] ¼­¿ïƯº°½Ã ±¤Áø±¸ Á߰ 341-18       Tel : 02)3437-0901